Researchers have developed a personalized blood test that may offer a faster, less invasive way to track high-grade glioma progression.

One assay applies to bioprocesses that use the HEK293 human embryonic kidney cell line, often used in gene therapy development.

Codetta Bio, a leader in multi-omics innovation, today announced its presence at the American Association for Cancer Research (AACR) Annual Meeting 2025, where the company will officially launch the ...

ProBio, a global contract development and manufacturing organization (CDMO), announced that it will present six poster presentations at the American Society of Gene and Cell Therapy (ASGCT) 28th ...